Literature DB >> 17189663

Synthesis and cytotoxicity of some new eriocalyxin B derivatives.

Yu Zhao1, Xue-Mei Niu, Li-Ping Qian, Ze-Yuan Liu, Qin-Shi Zhao, Han-Dong Sun.   

Abstract

Eriocalyxin B (1) was regarded as the promising candidate for new anticancer agent because of its potent activity and novel mechanism of action. Systematic modifications of 1 were done, and nineteen derivatives were synthesized and their cytotoxicities against five tumor cell lines were evaluated. The structure-activity relationship (SAR) of 1 confirmed that the alpha,beta-unsaturated ketone moieties in ring A and D are the leading active sites; the 7,20-epoxy moiety, OH-6 and OH-7 play an important role in keeping the cytotoxicity. The 6,7-seco derivative 19 had remarkable activity while derivative 20 oxidized from 19 was completely inactive, which suggested that the carboxyl group could destroy the cytoxicity of 20 despite the presence of alpha,beta-unsaturated ketone moiety.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189663     DOI: 10.1016/j.ejmech.2006.11.004

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3.

Authors:  Xiaokui Yu; Li He; Peng Cao; Qiang Yu
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

2.  Identification and validation of p50 as the cellular target of eriocalyxin B.

Authors:  Ling-Mei Kong; Xu Deng; Zhi-Li Zuo; Han-Dong Sun; Qin-Shi Zhao; Yan Li
Journal:  Oncotarget       Date:  2014-11-30

3.  Scalable synthesis enabling multilevel bio-evaluations of natural products for discovery of lead compounds.

Authors:  Lizhi Zhu; Wenjing Ma; Mengxun Zhang; Magnolia Muk-Lan Lee; Wing-Yan Wong; Brandon Dow Chan; Qianqian Yang; Wing-Tak Wong; William Chi-Shing Tai; Chi-Sing Lee
Journal:  Nat Commun       Date:  2018-03-29       Impact factor: 14.919

4.  Synthesis and antitumor evaluation of neolaxiflorin B inspired compounds.

Authors:  Jing-Ping Liu; Ye-Zhi Xiao; Yu Hu; Xiao-Nian Li; Ming-Jiang Wu; Yong Zhao; Yan Zhao; Ze-Jin Ma; Jing Shen
Journal:  Drug Des Devel Ther       Date:  2019-08-23       Impact factor: 4.162

5.  Harnessing Natural Products by a Pharmacophore-Oriented Semisynthesis Approach for the Discovery of Potential Anti-SARS-CoV-2 Agents.

Authors:  Yuan-Fei Zhou; Bing-Chao Yan; Qian Yang; Xin-Yan Long; Dan-Qi Zhang; Rong-Hua Luo; Han-Yu Wang; Han-Dong Sun; Xiao-Song Xue; Yong-Tang Zheng; Pema-Tenzin Puno
Journal:  Angew Chem Int Ed Engl       Date:  2022-05-12       Impact factor: 16.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.